NEW YORK (GenomeWeb News) – Becton Dickinson said today that it and Hologic's Gen-Probe business have settled a patent dispute, and the company has been granted a license from Gen-Probe to make, use, and sell certain products that BD had been accused of infringing.

BD will make payments to Gen-Probe as part of the settlement, including upfront fees and ongoing royalties. BD did not specify the amounts of the payments but said they are not material to the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.